|
1
|
Pidkovka NA, Cherepanova OA, Yoshida T,
Alexander MR, Deaton RA, Thomas JA, Leitinger N and Owens GK:
Oxidized phospholipids induce phenotypic switching of vascular
smooth muscle cells in vivo and in vitro. Circ Res. 101:792–801.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Berliner JA and Watson AD: A role for
oxidized phospholipids in atherosclerosis. N Engl J Med. 353:9–11.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Libby P, Ridker PM and Hansson GK:
Progress and challenges in translating the biology of
atherosclerosis. Nature. 473:317–325. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lacolley P, Regnault V, Nicoletti A, Li Z
and Michel JB: The vascular smooth muscle cell in arterial
pathology: A cell that can take on multiple roles. Cardiovasc Res.
95:194–204. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hata A: Functions of microRNAs in
cardiovascular biology and disease. Annu Rev Physiol. 75:69–93.
2013. View Article : Google Scholar
|
|
6
|
Kang H and Hata A: MicroRNA regulation of
smooth muscle gene expression and phenotype. Curr Opin Hematol.
19:224–231. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
McDonald RA, Hata A, MacLean MR, Morrell
NW and Baker AH: MicroRNA and vascular remodelling in acute
vascular injury and pulmonary vascular remodelling. Cardiovasc Res.
93:594–604. 2012. View Article : Google Scholar :
|
|
8
|
Cheng Y, Liu X, Yang J, Lin Y, Xu DZ, Lu
Q, Deitch EA, Huo Y, Delphin ES and Zhang C: MicroRNA-145, a novel
smooth muscle cell phenotypic marker and modulator, controls
vascular neointimal lesion formation. Circ Res. 105:158–166. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Cordes KR, Sheehy NT, White MP, Berry EC,
Morton SU, Muth AN, Lee TH, Miano JM, Ivey KN and Srivastava D:
miR-145 and miR-143 regulate smooth muscle cell fate and
plasticity. Nature. 460:705–710. 2009.PubMed/NCBI
|
|
10
|
Davis BN, Hilyard AC, Nguyen PH, Lagna G
and Hata A: Induction of microRNA-221 by platelet-derived growth
factor signaling is critical for modulation of vascular smooth
muscle phenotype. J Biol Chem. 284:3728–3738. 2009. View Article : Google Scholar :
|
|
11
|
Liu X, Cheng Y, Zhang S, Lin Y, Yang J and
Zhang C: A necessary role of miR-221 and miR-222 in vascular smooth
muscle cell proliferation and neointimal hyperplasia. Circ Res.
104:476–487. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wang M, Li W, Chang GQ, Ye CS, Ou JS, Li
XX, Liu Y, Cheang TY, Huang XL and Wang SM: MicroRNA-21 regulates
vascular smooth muscle cell function via targeting tropomyosin 1 in
arteriosclerosis obliterans of lower extremities. Arterioscler
Thromb Vasc Biol. 31:2044–2053. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chan MC, Hilyard AC, Wu C, Davis BN, Hill
NS, Lal A, Lieberman J, Lagna G and Hata A: Molecular basis for
antagonism between PDGF and the TGFbeta family of signalling
pathways by control of miR-24 expression. EMBO J. 29:559–573. 2010.
View Article : Google Scholar :
|
|
14
|
Ji R, Cheng Y, Yue J, Yang J, Liu X, Chen
H, Dean DB and Zhang C: MicroRNA expression signature and
antisense-mediated depletion reveal an essential role of microRNA
in vascular neointimal lesion formation. Circ Res. 100:1579–1588.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Sun SG, Zheng B, Han M, Fang XM, Li HX,
Miao SB, Su M, Han Y, Shi HJ and Wen JK: miR-146a and Krüppel-like
factor 4 form a feedback loop to participate in vascular smooth
muscle cell proliferation. EMBO Rep. 12:56–62. 2011. View Article : Google Scholar
|
|
16
|
Zhang E and Wu Y: Dual effects of miR-155
on macrophages at different stages of atherosclerosis: LDL is the
key? Med Hypotheses. 83:74–78. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Tian FJ, An LN, Wang GK, Zhu JQ, Li Q,
Zhang YY, Zeng A, Zou J, Zhu RF, Han XS, et al: Elevated
microRNA-155 promotes foam cell formation by targeting HBP1 in
atherogenesis. Cardiovasc Res. 103:100–110. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Hao L, Wang XG, Cheng JD, You SZ, Ma SH,
Zhong X, Quan L and Luo B: The up-regulation of endothelin-1 and
down-regulation of miRNA-125a-5p, -155, and -199a/b-3p in human
atherosclerotic coronary artery. Cardiovasc Pathol. 23:217–223.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Weber M, Kim S, Patterson N, Rooney K and
Searles CD: MiRNA-155 targets myosin light chain kinase and
modulates actin cytoskeleton organization in endothelial cells. Am
J Physiol Heart Circ Physiol. 306:H1192–H1203. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Sun HX, Zeng DY, Li RT, Pang RP, Yang H,
Hu YL, Zhang Q, Jiang Y, Huang LY, Tang YB, et al: Essential role
of microRNA-155 in regulating endothelium-dependent vasorelaxation
by targeting endothelial nitric oxide synthase. Hypertension.
60:1407–1414. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhang LN, Wilson DW, da Cunha V, Sullivan
ME, Vergona R, Rutledge JC and Wang YX: Endothelial NO synthase
deficiency promotes smooth muscle progenitor cells in association
with upregulation of stromal cell-derived factor-1alpha in a mouse
model of carotid artery ligation. Arterioscler Thromb Vasc Biol.
26:765–772. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Boyle JJ, Weissberg PL and Bennett MR:
Tumor necrosis factor-alpha promotes macrophage-induced vascular
smooth muscle cell apoptosis by direct and autocrine mechanisms.
Arterioscler Thromb Vasc Biol. 23:1553–1558. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Gough PJ, Gomez IG, Wille PT and Raines
EW: Macrophage expression of active MMP-9 induces acute plaque
disruption in apoE-deficient mice. J Clin Invest. 116:59–69. 2006.
View Article : Google Scholar
|
|
24
|
Ishida N, Hayashi K, Hattori A, Yogo K,
Kimura T and Takeya T: CCR1 acts downstream of NFAT2 in
osteoclastogenesis and enhances cell migration. J Bone Miner Res.
21:48–57. 2006. View Article : Google Scholar
|
|
25
|
Erl W, Hristov M, Neureuter M, Yan ZQ,
Hansson GK and Weber PC: HMG-CoA reductase inhibitors induce
apoptosis in neointima-derived vascular smooth muscle cells.
Atherosclerosis. 169:251–258. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Fichtlscherer S, De Rosa S, Fox H,
Schwietz T, Fischer A, Liebetrau C, Weber M, Hamm CW, Röxe T,
Müller-Ardogan M, et al: Circulating microRNAs in patients with
coronary artery disease. Circ Res. 107:677–684. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Raitoharju E, Lyytikäinen LP, Levula M,
Oksala N, Mennander A, Tarkka M, Klopp N, Illig T, Kähönen M,
Karhunen PJ, et al: miR-21, miR-210, miR-34a, and miR-146a/b are
up-regulated in human atherosclerotic plaques in the Tampere
Vascular Study. Atherosclerosis. 219:211–217. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Nazari-Jahantigh M, Wei Y, Noels H, Akhtar
S, Zhou Z, Koenen RR, Heyll K, Gremse F, Kiessling F, Grommes J, et
al: MicroRNA-155 promotes atherosclerosis by repressing Bcl6 in
macrophages. J Clin Invest. 122:4190–4202. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Martin MM, Buckenberger JA, Jiang J,
Malana GE, Nuovo GJ, Chotani M, Feldman DS, Schmittgen TD and Elton
TS: The human angiotensin II type 1 receptor +1166 A/C polymorphism
attenuates microRNA-155 binding. J Biol Chem. 282:24262–24269.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
O’Connell RM, Taganov KD, Boldin MP, Cheng
G and Baltimore D: MicroRNA-155 is induced during the macrophage
inflammatory response. Proc Natl Acad Sci USA. 104:1604–1609. 2007.
View Article : Google Scholar
|
|
31
|
Zhu N, Zhang D, Chen S, Liu X, Lin L,
Huang X, Guo Z, Liu J, Wang Y, Yuan W, et al: Endothelial enriched
microRNAs regulate angiotensin II-induced endothelial infammation
and migration. Atherosclerosis. 215:286–293. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Ceppi M, Pereira PM, Dunand-Sauthier I,
Barras E, Reith W, Santos MA and Pierre P: MicroRNA-155 modulates
the inter-leukin-1 signaling pathway in activated human
monocyte-derived dendritic cells. Proc Natl Acad Sci USA.
106:2735–2740. 2009. View Article : Google Scholar
|
|
33
|
Taganov KD, Boldin MP, Chang KJ and
Baltimore D: NF-kappaB-dependent induction of microRNA miR-146, an
inhibitor targeted to signaling proteins of innate immune
responses. Proc Natl Acad Sci USA. 103:12481–12486. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Graff JW, Dickson AM, Clay G, McCaffrey AP
and Wilson ME: Identifying functional microRNAs in macrophages with
polarized phenotypes. J Biol Chem. 287:21816–21825. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Heeneman S, Sluimer JC and Daemen MJ:
Angiotensin-converting enzyme and vascular remodeling. Circ Res.
101:441–454. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Donners MM, Wolfs IM, Stöger LJ, van der
Vorst EP, Pöttgens CC, Heymans S, Schroen B, Gijbels MJ and de
Winther MP: Hematopoietic miR155 deficiency enhances
atherosclerosis and decreases plaque stability in hyperlipidemic
mice. PLoS One. 7:e358772012. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Naseem KM: The role of nitric oxide in
cardiovascular diseases. Mol Aspects Med. 26:33–65. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Albrecht EW, Stegeman CA, Heeringa P,
Henning RH and van Goor H: Protective role of endothelial nitric
oxide synthase. J Pathol. 199:8–17. 2003. View Article : Google Scholar
|
|
39
|
Casscells W: Migration of smooth muscle
and endothelial cells. Critical events in restenosis. Circulation.
86:723–729. 1992. View Article : Google Scholar : PubMed/NCBI
|
